• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home / Covid Update

Problem not of COVID vaccine shortage but of planning: Centre

Union Health Secretary Rajesh Bhushan said so far states and UTs have received 13,10,90,370 vaccine doses, out of which the total consumption, including wastage, has been 11,43,69,677

  • Press Trust of India
  • Last Updated : April 13, 2021, 18:54 IST
  • Follow
Foreign Secretary Harsh Vardhan Shringla said that India had warned of reciprocal measures, If the UK does not address its concerns over the new travel rules relating to Covid-19 vaccine certification and has branded them as discriminatory.
  • Follow

New Delhi: Over 1.67 crore COVID-19 vaccine doses are still available with states and UTs, the Centre said on April 13, underlining that the problem is not of vaccine shortage but of better planning.

Addressing a press conference, Union Health Secretary Rajesh Bhushan said so far states and UTs have received 13,10,90,370 vaccine doses, out of which the total consumption, including wastage, has been 11,43,69,677.

“As per 11 am data, unutilised doses available with states and union territories for administration is 1,67,20,693. From now till April end, 2,01,22,960 doses are in supply pipeline to states and UTs,” he said.

“This clearly shows that the problem is of lack of better planning, not of vaccine doses shortage. We have made available vaccine doses to states and UTs from time to time and as we told you earlier that to bigger states we give supply of four days at once and on fourth and fifth day we replenish the supply. For smaller states, at once we supply 7-8 days vaccine doses and on seventh or eighth day their supply is replenished,” he added.

Bhushan said each state needs to ascertain at cold chain points how many unutilised doses are lying and if necessary then from one cold chain point to another the doses have to be reappropriated based on the consumption patterns. “In any state, the case might be that in one district more consumption is taking place while in another there is less consumption. Our request to state governments to ascertain where the doses can be reappropriated from,” he added. Bhushan also said Kerala has zero wastage of vaccine doses while on the other hand there are states which are registering 8-9% wastage.

Giving details of coronavirus situation in the country, Bhushan said the previous highest surge has already been crossed and the trend is going upward and that is a cause for worry and that is something they continuously share with the states and UTs and try to help them tackle the pandemic in a more effective manner.

“The previous highest surge was 94,372 daily cases in September which is now 1,61,736 every day. There are 53 central teams which are camping in 53 districts of the country which are showing a surge in cases and these central teams are helping the district administration as well the state administration, particularly health department and revenue officials, in tackling the pandemic,” he added.

The daily deaths are also showing an increasing trend. But the previous surge was 1,104 and it is presently 879 deaths.

He said Maharashtra, UP, Delhi, Haryana and Gujarat are among states of concern.

NITI Aayog member (Health) V K Paul said a serious situation is emerging. While the situation is worse in some states it is a countrywide problem and there has to be continued focus on test, track, trace and treat strategy and following COVID appropriate behaviour as well as embracing the vaccine, he said.

“Everyone should wear a mask,” he said.

Amid reports of shortage of remdesivir, he said the drug is to be given only to hospitalised, serious patients and those on oxygen support, and there is no question of its use in home setting and it is not to be procured from chemist shops.

“As shortage of remdesivir was reported in some areas, its export was banned. This medicine is now available in plenty. We appeal to physicians to do rational, judicious use of remdesivir in hospitalised patients,” he said. Paul also stressed on embracing Ayush products for boosting immunity.

Published: April 13, 2021, 18:36 IST

Download Money9 App for the latest updates on Personal Finance.

  • Covid vaccine
  • COVID-19 vaccine
  • vaccine

Related

  • Covid first wave led to increase in antibiotic misuse in India: Study
  • Centre rushes teams to six states reporting a high number of Covid cases
  • Covid-19: India records 46,617 new cases; national recovery rate crosses 97%
  • India’s medical infrastructure well prepared to deal with possible third Covid wave, says FM
  • Karnataka makes RT-PCR negative report, vaccine certificate must for Kerala travellers
  • National Doctors’ Day: Over 1500 doctors sacrificed their lives in fight against Covid-19

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • DGCA प्रमुख ने सुचारू उड़ान संचालन सुनिश्चित करने के लिए पायलटों से मांगा सहयोग
  • रेपो दर में कटौती से घर के लिए कर्ज होगा सस्ता, मांग बढ़ेगी: रियल एस्टेट
  • मीशो के 5,421 करोड़ रुपये के आईपीओ को दूसरे दिन मिला 7.97 गुना अभिदान
  • इंडिगो को अगले साल 10 फरवरी तक उड़ान संचालन पूरी तरह बहाल होने की उम्मीद
  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close